As a world-leading service provider of antibody development and engineering, Creative Biolabs has combined artificial intelligence, big data, and machine learning to generate a novel artificial intelligence (AI)-powered computational antibody drug discovery platform to predict antibody-antigen binding and provide antibody drug candidates. This platform has been considered as an attractive strategy for producing human antibodies with high specificity and affinity. Learn more: AI technologies Platform